Financial Comparison: Precision Therapeutics (NASDAQ:POAI) versus Avanos Medical (NASDAQ:AVNS)

Precision Therapeutics (NASDAQ:POAI) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Precision Therapeutics and Avanos Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Therapeutics 0 0 0 0 N/A
Avanos Medical 2 0 2 0 2.00

Avanos Medical has a consensus price target of $60.33, suggesting a potential upside of 51.21%. Given Avanos Medical’s higher probable upside, analysts plainly believe Avanos Medical is more favorable than Precision Therapeutics.

Volatility & Risk

Precision Therapeutics has a beta of 2.42, indicating that its stock price is 142% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500.

Profitability

This table compares Precision Therapeutics and Avanos Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Precision Therapeutics -925.08% -714.98% -255.28%
Avanos Medical 2.58% 4.92% 3.42%

Earnings and Valuation

This table compares Precision Therapeutics and Avanos Medical’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Precision Therapeutics $1.41 million 14.80 -$10.09 million N/A N/A
Avanos Medical $652.30 million 2.91 $57.50 million $0.82 48.66

Avanos Medical has higher revenue and earnings than Precision Therapeutics.

Insider & Institutional Ownership

1.2% of Precision Therapeutics shares are held by institutional investors. Comparatively, 93.4% of Avanos Medical shares are held by institutional investors. 13.4% of Precision Therapeutics shares are held by insiders. Comparatively, 1.6% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Avanos Medical beats Precision Therapeutics on 8 of the 11 factors compared between the two stocks.

About Precision Therapeutics

Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was founded in 2002 and is based in Eagan, Minnesota.

About Avanos Medical

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. The company also offers Game Read, a product for pain management and rehabilitation of patients recovering from orthopedic surgery or sports-related injuries; GRPro 2.1, a cold and compression therapy system; Med4Elite, a multi-modality therapy unit; ATX Wraps; and various product accessories. In addition, it sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.